Actively Recruiting
Observational Study on Insurance Approval, Costs, and Surgery Outcomes in Adults With Various Advanced Skin Cancers Receiving Neoadjuvant Therapy
Led by Ohio State University Comprehensive Cancer Center · Updated on 2026-06-25
70
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the timing, costs, insurance approval process, and surgical outcomes for patients with various skin cancers who receive neoadjuvant therapy, which is treatment given before surgery. This observational study focuses on both off-label use, where treatments are not FDA-approved for the specific cancer type, and on-label use. The study aims to understand delays in insurance approval for off-label treatments and how these delays may affect patient outcomes. Participants include patients with resectable or potentially resectable Merkel cell carcinoma, mucosal melanoma, basal cell carcinoma, and other rare skin cancers. They complete surveys and allow their medical records to be reviewed. The study observes the real-life timing and costs involved in obtaining insurance approval and drugs, as well as the extent of surgical resection after neoadjuvant immunotherapy or other standard treatments given over approximately 12 weeks prior to surgery. During the study, participants provide survey responses and medical records are reviewed to collect data on insurance approval time, coverage methods, out-of-pocket expenses, and surgical results. These outcomes are tracked for up to 17 weeks. Researchers assess these factors to better understand the impact of insurance processes on treatment timing and surgical outcomes in real-world clinical practice.
CONDITIONS
Brief Title
Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
Research Team
T
The Ohio State University Comprehensive Cancer Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here